Drug
LOXO-783
LOXO-783 is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
active_not_recruiting125%
completed375%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingphase_1
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
NCT05307705
completedphase_1
A Study of [14C]-LOXO-783 in Healthy Adult Participants
NCT06102512
completedphase_1
A Study to Evaluate the Effect of Food on LOXO-783 in Healthy Participants
NCT06028425
completedphase_1
A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy Participants
NCT05894928
Clinical Trials (4)
Showing 4 of 4 trials
NCT05307705Phase 1
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
NCT06102512Phase 1
A Study of [14C]-LOXO-783 in Healthy Adult Participants
NCT06028425Phase 1
A Study to Evaluate the Effect of Food on LOXO-783 in Healthy Participants
NCT05894928Phase 1
A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy Participants
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4